project id: TCGA-SKCM; case submitter id: TCGA-EE-A2GC; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 9.1; age at index: 82; days to birth: -30084; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1926; age at diagnosis: 30084; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2051.0; icd 10 code: C77.0; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of head, face and neck; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1246; initial weight: 470.0; sample id: 498b5692-1ff2-4d4e-b96a-9ce977a2f24f; sample submitter id: TCGA-EE-A2GC-06A; portion id: 938b3091-b34f-43bf-9b51-6bfe2d6206af; portion submitter id: TCGA-EE-A2GC-06A-11; slide id: b4472716-e0a8-47cc-9770-3cf8fec2a5c7; slide submitter id: TCGA-EE-A2GC-06A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 96.0; section location: TOP;